Gansu added 17 kinds of ethnic medicine as the basic medicine, triggering the industry's thinking on the development of ethnic medicine

[industry trends of pharmaceutical network] on July 24, Gansu Province issued the opinions on the implementation of improving the national basic drug system (hereinafter referred to as the opinions), in order to continuously improve the level of drug supply guarantee and meet the people's health drug demand The opinions regulates policies from catalog implementation, use, incentive, guarantee, quality improvement, monitoring and evaluation, data sharing and other aspects, adheres to the leading position of essential drugs and highlights its clinical value Gansu Province has strictly implemented the implementation of the national essential drug catalogue and opened a "green channel" for new varieties At the same time, in order to meet the drug demand of common diseases, frequently occurring diseases, plateau diseases and endemic diseases, the national drug varieties in 2013 Gansu Province basic drug adjustment catalogue were extended to strengthen the monitoring of adverse reactions and timely transfer out the drugs that have been delisted or have more serious adverse reactions It is reported that Gansu Province has added 17 kinds of ethnic medicine as basic drugs, such as Anshen pill, Baimai ointment, 25weifei disease pill, 25weisongshi pill, 25weizhu pill, Jiebai pill (capsule, tablet), Qiweihonghuashusheng pill, Ruyi Zhenbao pill (tablet) Gansu Province issued a document to add 17 kinds of ethnic medicine as basic drugs, which is also a new driving force for the development of ethnic medicine It is understood that in the past few years, the development dilemma of ethnic medicine has brought anxiety to ethnic medicine enterprises The industry has repeatedly called for attention and support to the development of Chinese national medicine A personage in the industry proposed that the relevant departments should formulate practical laws and regulations for the research and development of traditional Chinese medicine and ethnic medicine, so that ethnic medicine can contribute to human health What is the bottleneck for the development of national medicine? According to the analysis of experts, the lack of talents and the improvement of innovation ability are important bottlenecks For a long time, there has been a serious shortage of R & D talents in China's ethnic medicine industry, and a serious lack of successors There are few compound talents and high-level talents Some ethnic medicine knowledge, characteristic diagnosis and treatment technology and methods are on the verge of being lost In terms of the innovation ability of ethnic medicine, a personage in the industry called for the second development of ethnic medicine She believed that compared with traditional Chinese medicine and chemical medicine, the innovation of ethnic medicine was difficult "Influenced by living habits, cultural heritage and other factors, national pharmaceutical enterprises are not easy to grow up, and it is difficult to give full play to their own advantages National pharmaceutical enterprises should use high and new technology to transform traditional industries and improve the product quality and modernization level of national medicine." The person said that China should have scientific data to prove the efficacy of ethnic medicine, improve the quality and standard of medicine through secondary development, so as to improve the quality of medicine It is understood that with the support of some policies, some pharmaceutical enterprises have also begun to strengthen the innovation of national medicine, enabling the development of national medicine For example, a pharmaceutical enterprise and more than 20 well-known units have formed a collaborative innovation mode of integration of production, learning and research to help national pharmaceutical innovation research and development and talent output In recent years, the state attaches great importance to the development of ethnic medicine According to the data, 43 ethnic medicine varieties have been added to the 2017 version of the national medical insurance drug catalog, with a growth rate of 95%, far exceeding the growth rate of 17.1% of the overall catalog In addition, the law of traditional Chinese medicine specifies that traditional Chinese medicine includes ethnic medicine Although the relevant departments clearly stated that "no supplement in principle", similar to Gansu Province, Yunnan Province, Guangxi and other regions with regional characteristics, the supplement of ethnic medicine is still within the allowable range For example, this time, the document issued by Gansu Province clearly stated that: adhere to the principle of science, openness, fairness and justice, select some ethnic medicine varieties appropriately, meet the drug demand of common diseases, frequently occurring diseases, plateau diseases and local diseases of the people in ethnic areas, and continue to use the ethnic medicine in 2013 Gansu Province basic drug adjustment catalogue However, on the road of the development of ethnic medicine, due to various reasons, the development of ethnic medicine is still subject to many constraints, and the safety, scientificity and feasibility of industrial development still need to be systematically explored In addition, the current evaluation system dominated by western medicine is also hindering the development and popularization of ethnic medicine According to the industry, on the basis of focusing on the practical application of ethnic medicine, we should speed up the basic research of ethnic medicine, such as Miao medicine, express ethnic medicine, such as Miao medicine, and spread and develop ethnic medicine in a language that the world can understand.